Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-12-07
2011-11-15
Davis, Zinna Northington (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S312000, C514S333000, C514S334000, C514S349000, C544S131000, C544S333000, C546S152000, C546S256000, C546S261000, C546S268100, C546S297000
Reexamination Certificate
active
08058272
ABSTRACT:
The present disclosure relates to XIAP inhibitor compound of the formula I:
REFERENCES:
patent: WO 2006/133147 (2006-12-01), None
patent: WO 2007/101347 (2007-09-01), None
Proudfoot et al., “Nonpeptidic, Monocharged, Cell Permeable Ligands for the p56lck SH2 Domain”, Journal of Medicinal Chemistry, 2001 vol. 44 No. 15 pp. 2421-2431.
Chen Ming
Chen Zhuoliang
Straub Christopher Sean
Wang Run-Ming David
Zawel Leigh
Davis Zinna Northington
Novartis AG
LandOfFree
Organic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Organic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Organic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4281118